|
End-of-day quote
Egyptian Exchange
2026-09-24
|
5-day change | 1st Jan Change | ||
| 255.66 EGP | -3.02% |
|
-8.86% | +301.67% |
| 08-13 | GlaxoSmithKline S.A.E Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 05-17 | GlaxoSmithKline Q1 consol net profit EGP 4.7 million | RE |
Stock exchange
Egyptian Exchange
BIOC 255.66 £
-3.02%
15.91M
£
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| BIOC | 255.66EGP | -3.02% | 15.91M £ |
Quotes 5-day view: GlaxoSmithKline S.A.E
End-of-day quote Egyptian Exchange| 2026-09-20 | 2026-09-21 | 2026-09-22 | 2026-09-23 | 2026-09-24 | |
|---|---|---|---|---|---|
| Last | EGP 273.69 | EGP 262.91 | EGP 271.12 | EGP 263.61 | EGP 255.66 |
| Volume | 70,592 | 160,731 | 200,298 | 46,484 | 62,220 |
| Change | -2.43% | -3.94% | +3.12% | -2.77% | -3.02% |
| Opening | EGP 280.50 | EGP 273.69 | EGP 262.91 | EGP 271.12 | EGP 263.61 |
| High | EGP 283.00 | EGP 275.00 | EGP 288.00 | EGP 275.00 | EGP 265.00 |
| Low | EGP 272.44 | EGP 247.03 | EGP 266.00 | EGP 263.00 | EGP 250.01 |
Performance
| 1 day | -3.02% | ||
| 1 week | -8.86% | ||
| Current month | -24.96% | ||
| 1 month | -43.56% | ||
| 3 months | +257.87% | ||
| 6 months | +325.04% | ||
| Current year | +301.67% | ||
| 1 year | +306.78% | ||
| 3 years | +698.94% | ||
| 5 years | +801.48% | ||
| 10 years | +2,190.86% |
Volumes
marketsDaily volume
62,220
Avg. Volume 20 sessions
146,920
Avg. Volume 20 sessions EGP
37,561,567.2
Avg. Volume 20 sessions USD
726,252.9
Record volume 1
2,414,902
Record volume 2
1,829,945
Record volume 3
1,576,204
Capital turnover ratio
0
Float rotation
0.06
Basic data
Market Cap (EGP)
21,351,240,370
Market Cap (USD)
412,433,727
Net sales ()
3,730,502,257
Net sales (USD)
72,060,682
Free-Float
2.91%
Free-Float capitalization (EGP)
622,345,979
Free-Float capitalization (USD)
12,021,619
Average Daily Capital Traded
0.18%
Indicators
Moving average 5 days
265.4
Moving average 20 days
300.79
Moving average 50 days
322.92
Moving average 100 days
197.44
Price spread / (MMA5)
+3.81%
Price spread / (MMA20)
+17.65%
Price spread / (MMA50)
+26.31%
Price spread / (MMA100)
-22.77%
RSI 9 days
28.02
RSI 14 days
36.27
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.02% | -8.86% | +306.78% | +698.94% | 412M | |
| +0.13% | +2.65% | +65.61% | +114.28% | 1,055B | |
| +0.20% | +0.46% | +52.60% | +69.24% | 654B | |
| -0.29% | +0.14% | +20.96% | +70.93% | 467B | |
| -0.85% | +0.98% | +41.29% | +44.38% | 348B | |
| +0.71% | +4.08% | +22.24% | +29.51% | 275B | |
| +1.23% | +0.42% | +14.57% | +12.13% | 258B | |
| +2.11% | +7.51% | +52.89% | +55.37% | 224B | |
| +0.83% | +0.55% | +35.99% | +101.70% | 187B | |
| 0.00% | -10.14% | -29.94% | -60.30% | 171B | |
| Average | +0.02% | +0.01% | +58.30% | +113.62% | 363.88B | |
| Weighted average by Cap. | +0.02% | +1.32% | +41.57% | +67.90% |
Historical Quotes: GlaxoSmithKline S.A.E
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 247.03 |  | 288 |
| 1 month | 247.03 | | 453 |
| Current year | 55.1 | | 609 |
| 1 year | 55.1 | | 609 |
| 3 years | 24.7 | | 609 |
| 5 years | 16.66 | | 609 |
| 10 years | 0 | | 609 |
Monthly variations
Annual variations
| 2026 | +301.67% | ||
| 2025 | +76.81% | ||
| 2024 | +1.27% | ||
| 2023 | -6.84% | ||
| 2022 | +23.58% | ||
| 2021 | +82.08% | ||
| 2020 | -14.17% | ||
| 2018 | -100.00% | ||
| 2017 | +81.72% | ||
| 2016 | -11.39% | ||
| 2015 | -10.00% | ||
| 2014 | -20.11% | ||
| 2013 | +53.22% | ||
| 2012 | +0.42% | ||
| 2011 | -39.24% | ||
| 2010 | +18.18% | ||
| 2009 | +24.72% | ||
| 2008 | -47.68% | ||
| 2007 | +0.89% | ||
| 2006 | +104.33% | ||
| 2005 | +6.65% |
- Stock Market
- Stocks
- BIOC Stock
- Quotes GlaxoSmithKline S.A.E
Select your edition
All financial news and data tailored to specific country editions
